Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Viruses|March 26, 2022
Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin-A Randomized Controlled Clinical TrialLone W Madsen, Peer B Christensen, Janne F Hansen, et al.
Frontiers in Cellular and Infection Microbiology|July 14, 2022
Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis CLone Wulff Madsen, Peer Brehm Christensen, Anne Øvrehus, et al.
Microbiology Spectrum|July 25, 2024
Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patientsUlrik Fahnøe, Lone Wulff Madsen, Peer Brehm Christensen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 15, 2020
Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital settingLone Wulff Madsen, Susan Olaf Lindvig, Line Dahlerup Rasmussen, et al.
Journal of Virology|December 13, 2023
Full-length sequence analysis of hepatitis C virus genotype 3b strains and development of an <i>in vivo</i> infectious 3b cDNA clonePriyanka Shukla Bajpai, Laura Collignon, Christina Sølund, et al.
Clinics and Research in Hepatology and Gastroenterology|March 19, 2021
Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapyJeffrey V Lazarus, Camila A Picchio, Danielle Guy, et al.
The International Journal on Drug Policy|July 19, 2025
Peer-delivered mail-order self-collection and linkage to treatment for hepatitis C virus infection among users of a harm reduction service in DenmarkJonas Demant, Stephen Strunge Nilsson, Louise Krohn-Dehli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 14, 2020
Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended useAnna Christine Nilsson, Dorte Kinggaard Holm, Ulrik Stenz Justesen, et al.
Plos One|September 4, 2020
Hepatitis C prevalence in Denmark in 2016-An updated estimate using multiple national registersStine Nielsen, Janne Fuglsang Hansen, Gordon Hay, et al.
Plos One|December 10, 2020
Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAsJacob Søholm, Janne Fuglsang Hansen, Belinda Mössner, et al.
Pageof 3